🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the safety and efficacy of Arazlo Lot...
Status
Completed
Location
The Dermatology Institute of Boston
Start Date
2021-02-01
Trial ID
NCT05704114
Treatments Being Tested
This is an open label, prospective study to evaluate therapeutic potential ...
Status
Unknown
Location
McGill University
Start Date
2008-10
Trial ID
NCT00779896
Treatments Being Tested
This is a randomized, double-blind study of excimer (308-nm UVB) laser adde...
Status
Terminated
Location
University of Utah Department of Dermatology
Start Date
2010-01
Trial ID
NCT01094717
Treatments Being Tested
This is a multicenter, randomized, double-blind, vehicle-controlled, 12-wee...
Status
Completed
Location
Valeant Site 19
Start Date
2017-06-29
Trial ID
NCT03168321
Treatments Being Tested
The purpose of this study is to determine whether topical tazarotene (Tazor...
Status
Completed
Location
Columbia University Medical Center
Start Date
2005-08
Trial ID
NCT00648986
Treatments Being Tested
Safety and Efficacy of IDP-123 Lotion (0.045% tazarotene) to Tazorac® (taza...
Status
Completed
Location
Valeant Site 03
Start Date
2015-11
Trial ID
NCT02938494
Treatments Being Tested
The objective of this study is to evaluate the long-term safety of IDP-118 ...
Status
Completed
Location
Valeant Site 6
Start Date
2015-08-11
Trial ID
NCT02462083
Treatments Being Tested
Enrollment of subjects with mild to moderate facial acne vulgaris. Co-Prim...
Status
Completed
Location
Center for Dermatology Clinical Research Inc.
Start Date
2017-07-06
Trial ID
NCT03292640
Treatments Being Tested
The primary objective of this study is to compare the safety and efficacy o...
Status
Unknown
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02525822
Treatments Being Tested
A single-blind (investigator-blinded), randomized, parallel group, single c...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01016977